These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1442491)

  • 1. A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function.
    Bashir Y; Paul VE; Griffith MJ; Sneddon JF; Farrell TG; Ward DE; Camm AJ
    Am Heart J; 1992 Nov; 124(5):1233-40. PubMed ID: 1442491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant xamoterol or metoprolol in patients with malignant ventricular arrhythmia resistant to amiodarone.
    Paul V; Griffith M; Ward DE; Camm AJ
    Lancet; 1989 Aug; 2(8658):302-5. PubMed ID: 2569105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
    Steinbeck G; Greene HL
    Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
    Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia.
    Jung W; Mletzko R; Manz M; Nitsch J; Lüderitz B
    Pacing Clin Electrophysiol; 1993 Apr; 16(4 Pt 1):778-88. PubMed ID: 7683805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia.
    Tonet J; Frank R; Fontaine G; Grosgogeat Y
    Pacing Clin Electrophysiol; 1988 Nov; 11(11 Pt 2):1984-9. PubMed ID: 2463576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of the combination of low doses of beta-blockers and amiodarone in the treatment of refractory ventricular tachycardia].
    Tonet J; Frank R; Fontaine G; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1511-7. PubMed ID: 2573326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias.
    Kowey PR; Marinchak RA; Rials SJ; Rubin AM; Smith L
    Am Heart J; 1993 Jun; 125(6):1628-32. PubMed ID: 8498304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M; Cappato R; Kuck KH
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity.
    Mahmarian JJ; Smart FW; Moyé LA; Young JB; Francis MJ; Kingry CL; Verani MS; Pratt CM
    Am J Cardiol; 1994 Oct; 74(7):681-6. PubMed ID: 7524296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
    Man KC; Williamson BD; Niebauer M; Daoud E; Bakr O; Strickberger SA; Hummel JD; Kou W; Morady F
    Am J Cardiol; 1994 Dec; 74(11):1119-23. PubMed ID: 7977070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent.
    Singh BN
    Am J Cardiol; 1996 Aug; 78(4A):41-53. PubMed ID: 8780328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
    Manolis AS; Uricchio F; Estes NA
    Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.